rs11188410

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_002860.4(ALDH18A1):​c.558+289G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0593 in 152,276 control chromosomes in the GnomAD database, including 297 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.059 ( 297 hom., cov: 33)

Consequence

ALDH18A1
NM_002860.4 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: 0.00300

Publications

0 publications found
Variant links:
Genes affected
ALDH18A1 (HGNC:9722): (aldehyde dehydrogenase 18 family member A1) This gene is a member of the aldehyde dehydrogenase family and encodes a bifunctional ATP- and NADPH-dependent mitochondrial enzyme with both gamma-glutamyl kinase and gamma-glutamyl phosphate reductase activities. The encoded protein catalyzes the reduction of glutamate to delta1-pyrroline-5-carboxylate, a critical step in the de novo biosynthesis of proline, ornithine and arginine. Mutations in this gene lead to hyperammonemia, hypoornithinemia, hypocitrullinemia, hypoargininemia and hypoprolinemia and may be associated with neurodegeneration, cataracts and connective tissue diseases. Alternatively spliced transcript variants, encoding different isoforms, have been described for this gene. [provided by RefSeq, Jul 2008]
ALDH18A1 Gene-Disease associations (from GenCC):
  • cutis laxa, autosomal dominant 3
    Inheritance: AD, SD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • ALDH18A1-related de Barsy syndrome
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, G2P, Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • autosomal recessive complex spastic paraplegia type 9B
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG, SUPPORTIVE, LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
  • P5CS deficiency
    Inheritance: SD Classification: DEFINITIVE Submitted by: ClinGen, Illumina
  • hereditary spastic paraplegia 9A
    Inheritance: AD, SD Classification: MODERATE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics
  • autosomal dominant complex spastic paraplegia type 9B
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • autosomal dominant cutis laxa
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 10-95636804-C-A is Benign according to our data. Variant chr10-95636804-C-A is described in ClinVar as Benign. ClinVar VariationId is 669715.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.0816 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002860.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ALDH18A1
NM_002860.4
MANE Select
c.558+289G>T
intron
N/ANP_002851.2
ALDH18A1
NM_001323413.2
c.558+289G>T
intron
N/ANP_001310342.1
ALDH18A1
NM_001323414.2
c.558+289G>T
intron
N/ANP_001310343.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ALDH18A1
ENST00000371224.7
TSL:1 MANE Select
c.558+289G>T
intron
N/AENSP00000360268.2
ALDH18A1
ENST00000371221.3
TSL:1
c.558+289G>T
intron
N/AENSP00000360265.3

Frequencies

GnomAD3 genomes
AF:
0.0594
AC:
9032
AN:
152158
Hom.:
298
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0478
Gnomad AMI
AF:
0.157
Gnomad AMR
AF:
0.0578
Gnomad ASJ
AF:
0.0230
Gnomad EAS
AF:
0.0446
Gnomad SAS
AF:
0.0891
Gnomad FIN
AF:
0.0764
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.0641
Gnomad OTH
AF:
0.0521
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0593
AC:
9034
AN:
152276
Hom.:
297
Cov.:
33
AF XY:
0.0601
AC XY:
4476
AN XY:
74462
show subpopulations
African (AFR)
AF:
0.0477
AC:
1983
AN:
41552
American (AMR)
AF:
0.0578
AC:
884
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.0230
AC:
80
AN:
3472
East Asian (EAS)
AF:
0.0449
AC:
233
AN:
5192
South Asian (SAS)
AF:
0.0885
AC:
427
AN:
4824
European-Finnish (FIN)
AF:
0.0764
AC:
811
AN:
10612
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.0641
AC:
4362
AN:
68008
Other (OTH)
AF:
0.0516
AC:
109
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
443
887
1330
1774
2217
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
100
200
300
400
500
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0564
Hom.:
320
Bravo
AF:
0.0560
Asia WGS
AF:
0.0590
AC:
206
AN:
3478

ClinVar

ClinVar submissions as Germline

Significance:Benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
0.83
DANN
Benign
0.47
PhyloP100
0.0030
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11188410; hg19: chr10-97396561; API